Stay updated on Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial

Sign up to get notified when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Footer updates: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T13:31:06.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The Publications section adds a note that publications are provided voluntarily by the person entering information about the study and pertain to the study results, and the revision label is updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T17:00:14.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page footer notice regarding government funding/operating status was removed, with no impact on the study details, eligibility criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T15:04:03.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The record now includes published results for NCT02225587, citing a 2021 Hum Vaccin Immunother article and associated GMT data. This addition updates the study results section with analyzed outcomes.
    Difference
    0.4%
    Check dated 2025-11-03T01:31:46.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    3%
    Check dated 2025-10-05T11:51:45.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Removed multiple drug-safety topics and added a new version tag (v3.1.0), indicating a content cleanup and revision upgrade.
    Difference
    0.4%
    Check dated 2025-09-28T09:27:40.000Z thumbnail image

Stay in the know with updates to Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.